Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

2.3%

1 terminated/withdrawn out of 43 trials

Success Rate

95.5%

+8.8% vs industry average

Late-Stage Pipeline

5%

2 trials in Phase 3/4

Results Transparency

0%

0 of 21 completed trials have results

Key Signals

8 recruiting

Enrollment reporting

Analytics

N/A
10(62.5%)
Phase 1/2
2(12.5%)
Phase 3
2(12.5%)
Phase 2
1(6.3%)
Phase 2/3
1(6.3%)
16Total
N/A(10)
Phase 1/2(2)
Phase 3(2)
Phase 2(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (43)

Showing 20 of 43 trials
NCT06892951Phase 1/2Recruiting

CaspoNEB: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis Pneumonia

Role: collaborator

NCT03058185Recruiting

Observatoire Des Patients Atteints de Laminopathies et Emerinopathies (Observatory for PAtients With Laminopathies and Emerinopathies)

Role: lead

NCT06642844Phase 3Recruiting

Bevacizumab-based Chemotherapy Adapted to Bevacizumab Pharmacokinetics in 1st-line Treatment

Role: collaborator

NCT05912608Not ApplicableEnrolling By Invitation

Optimal Strategy for Repair of Type A Acute Aortic Dissection

Role: collaborator

NCT05912634Enrolling By Invitation

Repair Versus Non-repair of the Aortic Arch in Type A Aortic Dissection

Role: collaborator

NCT05927090Enrolling By Invitation

Outcomes of Aortic Dissection Repair

Role: collaborator

NCT06168370Not ApplicableRecruiting

Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Fibrillation Patients After Transcatheter Aortic Valve Implantation

Role: collaborator

NCT03990558Recruiting

Recovery of Consciousness Following Intracerebral Hemorrhage

Role: collaborator

NCT02123940Phase 3Completed

Treatment Strategy in Patients With High-risk of Postextubation Distress in ICU Based on a Lung Ultrasound Score Versus Standard Strategy

Role: collaborator

NCT07105904Completed

Biological and Clinical Relevance of Quantra Viscoelastic Hemostatic Assay in Hemorrhagic Cardiac Surgery

Role: lead

NCT03671291Not ApplicableCompleted

Missed Opportunities to Pre-exposure Prophylaxis for HIV Infection on Person Newly Diagnosed With HIV

Role: collaborator

NCT07361744Active Not Recruiting

Change in Sleep Breathing During Hospital Admission for COPD Exacerbation

Role: collaborator

NCT03272724Recruiting

French National Observatory on Infective Endocarditis

Role: collaborator

NCT05949814Completed

EASY-TESTS: Evaluation of the Acceptability of Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex With Men (MSM) Who Accepted Targeted HIV/STI Testing, Recruited Through a Community-based Outreach Approach, Both Digital and In-person.

Role: collaborator

NCT03666091Completed

Study and Monitoring of Early Undifferentiated Arthritis

Role: collaborator

NCT06514235Recruiting

Image-guided Brachytherapy for Vaginal Cancer (EMBRAVE)

Role: collaborator

NCT07065825Not Yet Recruiting

Tumor Rupture During Robotic Partial Nephrectomy

Role: collaborator

NCT05977270Not ApplicableCompleted

The Effects of Lifebloom One on Physical Activity After Acquired Brain Injury

Role: collaborator

NCT04732689Completed

Intraoperative Hemodynamic Management and Postoperative Outcomes in Liver Transplantation

Role: collaborator

NCT06311708Recruiting

Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Role: collaborator